Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Dec;70(12):8549–8557. doi: 10.1128/jvi.70.12.8549-8557.1996

Vaccinia virions lacking the RNA helicase nucleoside triphosphate phosphohydrolase II are defective in early transcription.

C H Gross 1, S Shuman 1
PMCID: PMC190947  PMID: 8970979

Abstract

Temperature-sensitive mutations (ts10, ts18, and ts39) of the vaccinia virus RNA helicase nucleoside triphosphate phosphohydrolase II (NPH-II) result in the production of noninfectious progeny virions at the restrictive temperature. The noninfectious mutant particles contain the wild-type complement of virion core and envelope polypeptides, as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The results of Western blot (immunoblot) analysis indicate that these particles lack NPH-II, whereas other enzymatic components of the virus core are present. These components include the following: DNA-dependent RNA polymerase subunits rpo147, rpo132, rpo94, rpo35, rpo30, rpo22, and rpo18; early transcription initiation factor subunits A8 and D6; mRNA capping enzyme subunits D1 and D12; RNA cap 2'-O-methyltransferase; A18 DNA helicase; DNA-dependent ATPase NPH-I; and DNA topoisomerase. Although RNA polymerase is encapsidated by the mutant viruses, mRNA synthesis in vitro by permeabilized mutant virions is only 5 to 20% that of the wild-type virus, as judged by nucleoside monophosphate incorporation into acid-insoluble material. Moreover, the transcripts synthesized by the mutant particles are longer than normal and remain virion associated. Transcription initiation by mutant virions occurs accurately at an endogenous genomic promoter, albeit at reduced levels (1 to 7%) compared with that of wild-type virions. In contrast, extracts of the mutant virions catalyze the wild-type level of transcription from an exogenous template containing an early promoter. We conclude that NPH-II is required for early mRNA synthesis uniquely in the context of the virus particle. Possible roles in transcription termination and RNA transport are discussed.

Full Text

The Full Text of this article is available as a PDF (461.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn B. Y., Gershon P. D., Jones E. V., Moss B. Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor. Mol Cell Biol. 1990 Oct;10(10):5433–5441. doi: 10.1128/mcb.10.10.5433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bajszár G., Wittek R., Weir J. P., Moss B. Vaccinia virus thymidine kinase and neighboring genes: mRNAs and polypeptides of wild-type virus and putative nonsense mutants. J Virol. 1983 Jan;45(1):62–72. doi: 10.1128/jvi.45.1.62-72.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bayliss C. D., Condit R. C. The vaccinia virus A18R gene product is a DNA-dependent ATPase. J Biol Chem. 1995 Jan 27;270(4):1550–1556. doi: 10.1074/jbc.270.4.1550. [DOI] [PubMed] [Google Scholar]
  4. Broyles S. S., Moss B. DNA-dependent ATPase activity associated with vaccinia virus early transcription factor. J Biol Chem. 1988 Aug 5;263(22):10761–10765. [PubMed] [Google Scholar]
  5. Cong P., Shuman S. Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme. J Biol Chem. 1992 Aug 15;267(23):16424–16429. [PubMed] [Google Scholar]
  6. Deng L., Shuman S. A role for the H4 subunit of vaccinia RNA polymerase in transcription initiation at a viral early promoter. J Biol Chem. 1994 May 13;269(19):14323–14328. [PubMed] [Google Scholar]
  7. Drolet M., Phoenix P., Menzel R., Massé E., Liu L. F., Crouch R. J. Overexpression of RNase H partially complements the growth defect of an Escherichia coli delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3526–3530. doi: 10.1073/pnas.92.8.3526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Earl P. L., Hügin A. W., Moss B. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J Virol. 1990 May;64(5):2448–2451. doi: 10.1128/jvi.64.5.2448-2451.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fathi Z., Condit R. C. Genetic and molecular biological characterization of a vaccinia virus temperature-sensitive complementation group affecting a virion component. Virology. 1991 Mar;181(1):258–272. doi: 10.1016/0042-6822(91)90491-s. [DOI] [PubMed] [Google Scholar]
  10. Fathi Z., Condit R. C. Phenotypic characterization of a vaccinia virus temperature-sensitive complementation group affecting a virion component. Virology. 1991 Mar;181(1):273–276. doi: 10.1016/0042-6822(91)90492-t. [DOI] [PubMed] [Google Scholar]
  11. Gershowitz A., Boone R. F., Moss B. Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate. J Virol. 1978 Aug;27(2):399–408. doi: 10.1128/jvi.27.2.399-408.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gross C. H., Shuman S. Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase II, a DExH box RNA helicase. J Virol. 1995 Aug;69(8):4727–4736. doi: 10.1128/jvi.69.8.4727-4736.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gross C. H., Shuman S. The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding. J Virol. 1996 Mar;70(3):1706–1713. doi: 10.1128/jvi.70.3.1706-1713.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gross C. H., Shuman S. Vaccinia virus RNA helicase: nucleic acid specificity in duplex unwinding. J Virol. 1996 Apr;70(4):2615–2619. doi: 10.1128/jvi.70.4.2615-2619.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hagler J., Luo Y., Shuman S. Factor-dependent transcription termination by vaccinia RNA polymerase. Kinetic coupling and requirement for ATP hydrolysis. J Biol Chem. 1994 Apr 1;269(13):10050–10060. [PubMed] [Google Scholar]
  16. Hagler J., Shuman S. Stability of ternary transcription complexes of vaccinia virus RNA polymerase at promoter-proximal positions. J Biol Chem. 1992 Apr 15;267(11):7644–7654. [PubMed] [Google Scholar]
  17. Hagler J., Shuman S. Ternary complex formation by vaccinia virus RNA polymerase at an early viral promoter: analysis by native gel electrophoresis. J Virol. 1992 May;66(5):2982–2989. doi: 10.1128/jvi.66.5.2982-2989.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ink B. S., Pickup D. J. Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference. J Virol. 1989 Nov;63(11):4632–4644. doi: 10.1128/jvi.63.11.4632-4644.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. JOKLIK W. K. The purification fo four strains of poxvirus. Virology. 1962 Sep;18:9–18. doi: 10.1016/0042-6822(62)90172-1. [DOI] [PubMed] [Google Scholar]
  20. Johnson G. P., Goebel S. J., Paoletti E. An update on the vaccinia virus genome. Virology. 1993 Oct;196(2):381–401. doi: 10.1006/viro.1993.1494. [DOI] [PubMed] [Google Scholar]
  21. Kates J., Beeson J. Ribonucleic acid synthesis in vaccinia virus. I. The mechanism of synthesis and release of RNA in vaccinia cores. J Mol Biol. 1970 May 28;50(1):1–18. doi: 10.1016/0022-2836(70)90100-2. [DOI] [PubMed] [Google Scholar]
  22. Koonin E. V., Senkevich T. G. Vaccinia virus encodes four putative DNA and/or RNA helicases distantly related to each other. J Gen Virol. 1992 Apr;73(Pt 4):989–993. doi: 10.1099/0022-1317-73-4-989. [DOI] [PubMed] [Google Scholar]
  23. Li J., Broyles S. S. The DNA-dependent ATPase activity of vaccinia virus early gene transcription factor is essential for its transcription activation function. J Biol Chem. 1993 Sep 25;268(27):20016–20021. [PubMed] [Google Scholar]
  24. Luo Y., Hagler J., Shuman S. Discrete functional stages of vaccinia virus early transcription during a single round of RNA synthesis in vitro. J Biol Chem. 1991 Jul 15;266(20):13303–13310. [PubMed] [Google Scholar]
  25. Luo Y., Mao X., Deng L., Cong P., Shuman S. The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme. J Virol. 1995 Jun;69(6):3852–3856. doi: 10.1128/jvi.69.6.3852-3856.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Luo Y., Shuman S. Antitermination of vaccinia virus early transcription: possible role of RNA secondary structure. Virology. 1991 Nov;185(1):432–436. doi: 10.1016/0042-6822(91)90793-b. [DOI] [PubMed] [Google Scholar]
  27. Moss B. Regulation of vaccinia virus transcription. Annu Rev Biochem. 1990;59:661–688. doi: 10.1146/annurev.bi.59.070190.003305. [DOI] [PubMed] [Google Scholar]
  28. Pacha R. F., Meis R. J., Condit R. C. Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA. J Virol. 1990 Aug;64(8):3853–3863. doi: 10.1128/jvi.64.8.3853-3863.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Paolette E., Rosemond-Hornbeak H., Moss B. Two nucleid acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Purification and characterization. J Biol Chem. 1974 May 25;249(10):3273–3280. [PubMed] [Google Scholar]
  30. Paoletti E., Moss B. Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Nucleotide substrate and polynucleotide cofactor specificities. J Biol Chem. 1974 May 25;249(10):3281–3286. [PubMed] [Google Scholar]
  31. Schnierle B. S., Gershon P. D., Moss B. Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2897–2901. doi: 10.1073/pnas.89.7.2897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shuman S., Broyles S. S., Moss B. Purification and characterization of a transcription termination factor from vaccinia virions. J Biol Chem. 1987 Sep 5;262(25):12372–12380. [PubMed] [Google Scholar]
  33. Shuman S., Moss B. Bromouridine triphosphate inhibits transcription termination and mRNA release by vaccinia virions. J Biol Chem. 1989 Dec 15;264(35):21356–21360. [PubMed] [Google Scholar]
  34. Shuman S., Moss B. Factor-dependent transcription termination by vaccinia virus RNA polymerase. Evidence that the cis-acting termination signal is in nascent RNA. J Biol Chem. 1988 May 5;263(13):6220–6225. [PubMed] [Google Scholar]
  35. Shuman S., Spencer E., Furneaux H., Hurwitz J. The role of ATP in in vitro vaccinia virus RNA synthesis effects of AMP-PNP and ATP gamma S. J Biol Chem. 1980 Jun 10;255(11):5396–5403. [PubMed] [Google Scholar]
  36. Shuman S. Vaccinia virus RNA helicase. Directionality and substrate specificity. J Biol Chem. 1993 Jun 5;268(16):11798–11802. [PubMed] [Google Scholar]
  37. Shuman S. Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10935–10939. doi: 10.1073/pnas.89.22.10935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Simpson D. A., Condit R. C. Vaccinia virus gene A18R encodes an essential DNA helicase. J Virol. 1995 Oct;69(10):6131–6139. doi: 10.1128/jvi.69.10.6131-6139.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wilcock D., Smith G. L. Vaccinia virions lacking core protein VP8 are deficient in early transcription. J Virol. 1996 Feb;70(2):934–943. doi: 10.1128/jvi.70.2.934-943.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yuen L., Moss B. Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters. J Virol. 1986 Oct;60(1):320–323. doi: 10.1128/jvi.60.1.320-323.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES